RentRedi Unveils First Ever Money-Back Guarantee, Raising the Bar for Landlord Confidence Better Plant’s Jusu Launches Pure Essential Oils and Spritzers
Better Plant’s Jusu Launches Pure Essential Oils and Spritzers VANCOUVER, BC / ACCESSWIRE / August…
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation ‘Mindful Blend’
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) (“NeonMind” or…
Roscan Gold Intersects 3.5gpt over 17m in Fresh Rock at MS3 and 3.31gpt Gold over 16m at MS1 as Sulphide Zone Broadens at Depth
TORONTO, ON / ACCESSWIRE / August 17, 2021 / Roscan Gold Corporation (“Roscan” or the…
Stevia Corp. Settles $1,250,000 Principal Amount of a Toxic Senior Convertible Debenture with Institutional Investor for Restricted Stock
NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Stevia Corp. (OTC PINK:STEV) (‘Stevia…
Can B Corp. Closes Acquisition of Assets from TWS Pharma in CO to Significantly Expand Capabilities in Converting Hemp Biomass to Isolate Used in our CBD and Isomer Product Lines
Adds $5 Million in Processing Assets HICKSVILLE, NY / ACCESSWIRE / August 17, 2021 /…
FireFox Gold Significantly Extends the Mineralized Trend at the Mustajärvi Project, Finland
SODANKYLĂ„, FINLAND / ACCESSWIRE / August 17, 2021 / FireFox Gold Corp. (TSXV:FFOX)(OTCQB:FFOXF)(“FireFox” or the…
GlobalSign Secures eIDAS Qualified Trust Service Provider Recognition in the United Kingdom
First Certificate Authority in the World to Achieve the Recognition With forged vaccine identity cards…
Empower Clinics Wholly Owned Subsidiary MediSure Receives Approval of Health Canada Medical Device Establishment Licence (MDEL)
MediSure Canada has obtained a Health Canada Medical Device Establishment License (MDEL # 17716), to…
ETIAS.info Takes the Guesswork Out of Navigating the ETIAS Process
BARCELONA, SPAIN / ACCESSWIRE / August 7, 2021 / It is no secret that travel…
Expression of Interest for Construction of University Hospital Project in Kenya
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / Minaean SP Construction Corp. (TSXV:MSP)(Berlin and…
Mike Edwards Is the Subject of a New Interview
The career corporate executive sat down with a freelance journalist to discuss his life, his…
MorphoSys’ Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / August 17, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR)…
Alzecure Gives Live Streamed Strategy Update on Alzheimer’s Disease and NeuroreStore on September 1
STOCKHOLM, SE / ACCESSWIRE / August 17, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma…
Aduro Clean Technologies Announces Investor Relations Agreement with Digitonic Limited
SARNIA, ON / ACCESSWIRE / August 17, 2021 / Aduro Clean Technologies Inc. (CSE:ACT)(OTCQB:ACTHF)(FSE:9D50) (the…
StageZero Life Sciences Signs Definitive Agreement with Health Clinics Limited
StageZero to Expand Capabilities in Early Diagnosis and Prevention of Cancer and Other Diseases as…
Spark Power Builds Momentum Throughout Quarter; Optimistic About Second Half Performance
Second Quarter revenue grows 41.1% Year over Year to $65.4 million Renewables segment continues strong…
Neos Networks transforms Perth & Kinross Council’s infrastructure with the completion of its DCMS-funded Local Full Fibre Network project
Delivery achieved significantly ahead of schedule, despite the need to navigate challenges such as the…
Oxurion NV – Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science, the American Academy of Ophthalmology Journal
THR-687 is a potent pan-RGD integrin antagonist holding potential as next generation first line therapy…
Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil
Nasally administered Foralumab, once a day for 10 consecutive days, was well-tolerated and produced significant…
Basilea reports strong financial results for half-year 2021 with significantly increased cash flow from marketed brands and increases 2021 full-year guidance
CHF 46.1 million (+26% year-on-year) non-deferred Cresemba and Zevtera revenue, including CHF 23.6 million royalty…